Deccan Health Care (BOM:542248) Piotroski F-Score: 4 (As of Jul. 08, 2026) — Near Median


BOM:542248 Deccan Health Care Ltd BOM:542248
81 GF Score
Price ₹13.43
GF Value ₹26.20
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Deccan Health Care Piotroski F-Score?

Deccan Health Care BOM:542248 -1.97% 81 Piotroski F-Score is 4 as of Jul. 08, 2026, which is at its 10-year median of 4.00. GuruFocus rates BOM:542248 with a GF Score™ of 81/100 and a GF Value™ of ₹26.20 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 980 Drug Manufacturers companies, Deccan Health Care ranks worse than 61.02% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Deccan Health Care has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Deccan Health Care's Piotroski F-Score or its related term are showing as below:

BOM:542248' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 4   Max: 6
Current: 4

During the past 11 years, the highest Piotroski F-Score of Deccan Health Care was 6. The lowest was 3. And the median was 4.

Deccan Health Care  (BOM:542248) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Deccan Health Care Piotroski F-Score Related Terms


Deccan Health Care Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Deccan Health Care's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Deccan Health Care Piotroski F-Score Chart

Deccan Health Care Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 3.00 4.00 4.00 4.00

Deccan Health Care Quarterly Data
Sep20 Mar21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 4.00 0.00 0.00 4.00

BOM:542248 vs ZTS, UTHR: Piotroski F-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Deccan Health Care's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Deccan Health Care Piotroski F-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Deccan Health Care's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Deccan Health Care's Piotroski F-Score falls into.


BOM:542248
81GF Score
Deccan Health Care Ltd BOM:542248
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was ₹24.9 Mil.
Cash Flow from Operations was ₹-36.2 Mil.
Revenue was ₹819.0 Mil.
Gross Profit was ₹315.2 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was (1249.271 + 1489.089) / 2 = ₹1369.18 Mil.
Total Assets at the begining of this year (Mar25) was ₹1,249.3 Mil.
Long-Term Debt & Capital Lease Obligation was ₹27.0 Mil.
Total Current Assets was ₹1,297.3 Mil.
Total Current Liabilities was ₹340.5 Mil.
Net Income was ₹11.6 Mil.

Revenue was ₹750.6 Mil.
Gross Profit was ₹275.6 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was (1080.48 + 1249.271) / 2 = ₹1164.8755 Mil.
Total Assets at the begining of last year (Mar24) was ₹1,080.5 Mil.
Long-Term Debt & Capital Lease Obligation was ₹8.8 Mil.
Total Current Assets was ₹1,062.4 Mil.
Total Current Liabilities was ₹157.0 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Deccan Health Care's current Net Income (TTM) was 24.9. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Deccan Health Care's current Cash Flow from Operations (TTM) was -36.2. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=24.876/1249.271
=0.01991241

ROA (Last Year)=Net Income/Total Assets (Mar24)
=11.587/1080.48
=0.01072394

Deccan Health Care's return on assets of this year was 0.01991241. Deccan Health Care's return on assets of last year was 0.01072394. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Deccan Health Care's current Net Income (TTM) was 24.9. Deccan Health Care's current Cash Flow from Operations (TTM) was -36.2. ==> -36.2 <= 24.9 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=27.023/1369.18
=0.01973663

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=8.843/1164.8755
=0.00759137

Deccan Health Care's gearing of this year was 0.01973663. Deccan Health Care's gearing of last year was 0.00759137. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=1297.308/340.474
=3.81029976

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=1062.417/156.97
=6.76828056

Deccan Health Care's current ratio of this year was 3.81029976. Deccan Health Care's current ratio of last year was 6.76828056. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Deccan Health Care's number of shares in issue this year was 24.63. Deccan Health Care's number of shares in issue last year was 25.749. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=315.226/819.048
=0.38486877

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=275.604/750.579
=0.36718853

Deccan Health Care's gross margin of this year was 0.38486877. Deccan Health Care's gross margin of last year was 0.36718853. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=819.048/1249.271
=0.65562076

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=750.579/1080.48
=0.69467181

Deccan Health Care's asset turnover of this year was 0.65562076. Deccan Health Care's asset turnover of last year was 0.69467181. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+0+1+0+0+0+1+1+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Deccan Health Care has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
Deccan Health Care (BOM:542248) has a Piotroski F-Score of 4 as of Jul. 08, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Deccan Health Care and its competitors. This is near median its historical median of 4.00. Over the past decade, Deccan Health Care's Piotroski F-Score has ranged from 3.00 to 6.00. According to the industry distribution chart, Deccan Health Care ranks #598 out of 980 companies in the Drug Manufacturers industry, placing it in the top 61%.
Is Deccan Health Care's Piotroski F-Score too high?
Deccan Health Care's current Piotroski F-Score of 4 is near median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 6.00. The Drug Manufacturers industry median Piotroski F-Score is 5.00. Deccan Health Care's value of 4 is 20% below this industry median. Based on the distribution chart, Deccan Health Care ranks #598 out of 980 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Deccan Health Care has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Deccan Health Care's Piotroski F-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Deccan Health Care ranks #598 out of 980 companies for Piotroski F-Score. This places Deccan Health Care in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Deccan Health Care's value of 4 is 20% below this benchmark. Historically, Deccan Health Care's own Piotroski F-Score has ranged from 3.00 to 6.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, Deccan Health Care has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Drug Manufacturers company?
The median Piotroski F-Score among Drug Manufacturers companies is 5.00, based on 980 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Deccan Health Care's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Deccan Health Care and its competitors. For the Drug Manufacturers industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Deccan Health Care's current Piotroski F-Score is 4, which is near median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Deccan Health Care stock overvalued right now?
Based on GuruFocus' analysis, Deccan Health Care (BOM:542248) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹26.20, compared to a current price of ₹13.43 — trading 48.7% below its estimated fair value. The current Piotroski F-Score is 4, which is near median its 10-year median of 4.00 and 20% below the Drug Manufacturers industry median of 5.00. Deccan Health Care's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Deccan Health Care (BOM:542248), the current Piotroski F-Score is 4 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Deccan Health Care (BOM:542248) Overvalued in 2026?

Based on GuruFocus' analysis, Deccan Health Care stock appears to be undervalued. The current stock price of ₹13.43 is trading 48.7% below its estimated GF Value™ of ₹26.20. GuruFocus considers Deccan Health Care to be Significantly Undervalued.

Key valuation signals for BOM:542248:

  • Piotroski F-Score: 4 (near median its 10-year median of 4.00)
  • GF Value™: ₹26.20 vs. price of ₹13.43 (48.7% below fair value)
  • GF Score™: 81/100 with 6 warning signs
  • Industry Position: 20% below the Drug Manufacturers median (#598 of 980)

No single metric tells the full story. See the BOM:542248 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Deccan Health Care Business Description

Address 6-3-347/17/5/A/Back Position, Dwarakapuri Colony, Punjagutta, Hyderabad, TG, IND, 500082
Deccan Health Care Ltd is into developing, manufacturing, and marketing a broad range of healthcare products, including nutraceutical, cosmeceutical, and ayurveda products (Fast Moving Consumer Health Products). Its products are Nutraceutical Food Products and other supplements and medicines. The company is operating in a single segment of manufacturing of nutraceutical products. The company operates in India as well as exports its products to other countries, and the majority of its revenue comes from India.
81GF Score

Get the complete analysis for BOM:542248

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹13.43
Price
₹26.20
GF Value